Loading...

Recro Pharma, Inc.

REPHNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$2.09
$-0.01(-0.48%)

Recro Pharma, Inc. (REPH) Company Profile & Overview

Explore Recro Pharma, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Recro Pharma, Inc. (REPH) Company Profile & Overview

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOGeraldine Henwood

Contact Information

14843952400
490 Lapp Rd, Malvern, PA, 19341

Company Facts

185 Employees
IPO DateMar 7, 2014
CountryUS

Frequently Asked Questions

;